Abstract
This presentation was given at the American Academy of Neurology Annual Meeting.
| Original language | American English |
|---|---|
| State | Published - Apr 9 2011 |
| Event | American Academy of Neurology Annual Meeting (AAN) - Duration: Apr 23 2018 → … |
Conference
| Conference | American Academy of Neurology Annual Meeting (AAN) |
|---|---|
| Period | 04/23/18 → … |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Disciplines
- Public Health
- Epidemiology
Keywords
- Chantix
- Double-blind
- Friedreich's Ataxia
- Placebo-controlled pilot study
- Randomized
- Treatment
- Varenicline
Fingerprint
Dive into the research topics of 'Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix) in the Treatment of Friedreich’s Ataxia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver